Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 188,640 shares at $277.14 ($53.5M) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $53.5M VRTX by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $277.14 | 9,015 | $2.5M | 4.7% |
| 2 | $277.14 | 9,015 | $2.5M | 4.7% |
| 3 | $277.94 | 4,428 | $1.2M | 2.3% |
| 4 | $277.94 | 4,428 | $1.2M | 2.3% |
| 5 | $278.96 | 1,940 | $541K | 1.0% |
| 6 | $278.96 | 1,940 |
| $541K |
| 1.0% |
| 7 | $280.76 | 6,498 | $1.8M | 3.4% |
| 8 | $280.76 | 6,498 | $1.8M | 3.4% |
| 9 | $281.83 | 9,398 | $2.6M | 5.0% |
| 10 | $281.83 | 9,398 | $2.6M | 5.0% |
| 11 | $282.66 | 9,780 | $2.8M | 5.2% |
| 12 | $282.66 | 9,780 | $2.8M | 5.2% |
| 13 | $283.86 | 9,219 | $2.6M | 4.9% |
| 14 | $283.86 | 9,219 | $2.6M | 4.9% |
| 15 | $285.06 | 10,179 | $2.9M | 5.4% |
| 16 | $285.06 | 10,179 | $2.9M | 5.4% |
| 17 | $285.68 | 8,391 | $2.4M | 4.5% |
| 18 | $285.68 | 8,391 | $2.4M | 4.5% |
| 19 | $286.70 | 15,792 | $4.5M | 8.5% |
| 20 | $286.70 | 15,792 | $4.5M | 8.5% |
| 21 | $287.81 | 9,630 | $2.8M | 5.2% |
| 22 | $287.81 | 9,630 | $2.8M | 5.2% |
| 23 | $288.42 | 100 | $29K | 0.1% |
| Total | $283.47 avg | 188,640 | $53.5M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |